Literature DB >> 16929441

Antibiotic-impregnated PMMA hip spacers: Current status.

Konstantinos Anagnostakos1, Oliver Fürst, Jens Kelm.   

Abstract

The infection rate after primary hip arthroplasty lies at 1-2%. In the past few years, a two-stage protocol with the implantation of an antibiotic-loaded spacer has become a popular procedure in the treatment of infected hip joint arthroplasties. In this review, we pay special attention to the elution characteristics of the spacers, their mechanical stability and the clinical response. We conclude that hip spacers are an effective method in the treatment of hip joint infections, with success rates of over 90%.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16929441     DOI: 10.1080/17453670610012719

Source DB:  PubMed          Journal:  Acta Orthop        ISSN: 1745-3674            Impact factor:   3.717


  55 in total

1.  [Hip joint infections - Results of a questionnaire among 28 university orthopedic departments].

Authors:  K Anagnostakos; D Kohn
Journal:  Orthopade       Date:  2011-09       Impact factor: 1.087

2.  [Revision implants of the future: trends and new developments].

Authors:  S Winkler; F-X Köck; C Baier; H-R Springorum; A Beifuss; P Lechler; J Grifka; J Schaumburger
Journal:  Orthopade       Date:  2012-01       Impact factor: 1.087

3.  Econazole-releasing porous space maintainers for fungal periprosthetic joint infection.

Authors:  Alexander M Tatara; Allison J Rozich; Panayiotis D Kontoyiannis; Emma Watson; Nathaniel D Albert; George N Bennett; Antonios G Mikos
Journal:  J Mater Sci Mater Med       Date:  2018-05-11       Impact factor: 3.896

4.  Diagnosis of spacer-associated infection using quantitative cultures from sonicated antibiotics-loaded spacers: implications for the clinical outcome.

Authors:  J Esteban; I Gadea; C Pérez-Jorge; E Sandoval; J García-Cañete; R Fernandez-Roblas; A Blanco; L Prieto-Borja; J Cordero-Ampuero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-11-26       Impact factor: 3.267

Review 5.  Two-stage procedure in the treatment of late chronic hip infections--spacer implantation.

Authors:  Mohamed Sukeik; Fares S Haddad
Journal:  Int J Med Sci       Date:  2009-09-02       Impact factor: 3.738

Review 6.  Classification of hip joint infections.

Authors:  Konstantinos Anagnostakos; Nora Verena Schmid; Jens Kelm; Ulrich Grün; Jochen Jung
Journal:  Int J Med Sci       Date:  2009-09-01       Impact factor: 3.738

Review 7.  Mechanical complications and reconstruction strategies at the site of hip spacer implantation.

Authors:  Konstantinos Anagnostakos; Jochen Jung; Nora Verena Schmid; Eduard Schmitt; Jens Kelm
Journal:  Int J Med Sci       Date:  2009-09-03       Impact factor: 3.738

8.  Mechanical behaviour of standardized, endoskeleton-including hip spacers implanted into composite femurs.

Authors:  T Thielen; S Maas; A Zuerbes; D Waldmann; K Anagnostakos; J Kelm
Journal:  Int J Med Sci       Date:  2009-09-03       Impact factor: 3.738

9.  Elution of gentamicin and vancomycin from polymethylmethacrylate beads and hip spacers in vivo.

Authors:  Konstantinos Anagnostakos; Philippe Wilmes; Eduard Schmitt; Jens Kelm
Journal:  Acta Orthop       Date:  2009-04       Impact factor: 3.717

10.  Complications after spacer implantation in the treatment of hip joint infections.

Authors:  Jochen Jung; Nora Verena Schmid; Jens Kelm; Eduard Schmitt; Konstantinos Anagnostakos
Journal:  Int J Med Sci       Date:  2009-09-02       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.